Advertisement
Advertisement
BLLN
BillionToOne, Inc. Class A Common Stock
93.39
USDSponsored
+1.74
+1.90%
Aug 07, 15:59 UTC -4
Closed
After-Market
93.67
+0.28
+0.30%
BLLN Earnings Reports
Positive Surprise Ratio
BLLN beat 2 of 4 last estimates.
50%
Next Report
Date of Next Report
Dec 02, 2026
Estimate for Q3 26 (Revenue/ EPS)
$119.58M
/$0.20
Implied change from Q2 26 (Revenue/ EPS)
+9.26%
/+33.33%
Implied change from Q3 25 (Revenue/ EPS)
+43.17%
/+100.00%
BillionToOne, Inc. Class A Common Stock earnings per share and revenue
On Aug 05, 2026, BLLN reported earnings of 0.15 USD per share (EPS) for Q2 26, missing the estimate of 0.18 USD, resulting in a -20.21% surprise. Revenue reached 109.45 million, compared to an expected 111.55 million, with a -1.88% difference. The market reacted with a -38.89% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 9 analysts forecast an EPS of 0.20 USD, with revenue projected to reach 119.58 million USD, implying an increase of 33.33% EPS, and increase of 9.26% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Lantheus Holdings, Inc
Report Date
Aug 06, 2026 For Q2 26
Estimate
$1.31
Actual
$1.55
Surprise
+17.50%
ICU Medical Inc
Report Date
Aug 06, 2026 For Q2 26
Estimate
$1.95
Actual
$2.37
Surprise
+21.43%
Haemonetics Corporation
Report Date
Aug 06, 2026 For Q1 27
Estimate
$1.08
Actual
$1.13
Surprise
+4.82%
Prestige Consumer Healthcare Inc.
Report Date
Aug 06, 2026 For Q1 27
Estimate
$0.89
Actual
$0.98
Surprise
+10.01%
ResMed Inc.
Report Date
Aug 06, 2026 For Q4 26
Estimate
$2.91
Actual
$2.95
Surprise
+1.09%
Maravai LifeSciences Holdings, Inc. Class A Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.04
Actual
-$0.02
Surprise
+54.65%
BioLife Solutions Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.03
Actual
$0.04
Surprise
+17.65%
Canopy Growth Corporation Common Shares
Report Date
Aug 07, 2026 For Q1 27
Estimate
-$0.11
Actual
-$0.02
Surprise
+75.74%
Apyx Medical Corporation Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.07
Surprise
+16.27%
United-Guardian, Inc.
Report Date
Aug 07, 2026 For Q2 26
Estimate
-Actual
$0.16
Surprise
-
FAQ
What were BillionToOne, Inc. Class A Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, BillionToOne, Inc. Class A Common Stock reported EPS of $0.15, missing estimates by -20.21%, and revenue of $109.45M, -1.88% below expectations.
How did the market react to BillionToOne, Inc. Class A Common Stock's Q2 2026 earnings?
The stock price moved down -38.89%, changed from $149.97 before the earnings release to $91.65 the day after.
When is BillionToOne, Inc. Class A Common Stock expected to report next?
The next earning report is scheduled for Dec 02, 2026.
What are the forecasts for BillionToOne, Inc. Class A Common Stock's next earnings report?
Based on 9
analysts, BillionToOne, Inc. Class A Common Stock is expected to report EPS of $0.20 and revenue of $119.58M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement